ARCHIVES

Tafinlar Subgroup Data Shows Median OS of 20 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year

December 14, 1979

DCCP Payback System Saving $1 Million Year

December 3, 1982

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

November 3, 1995

Survey Show Better Understanding Of Breast Cancer

December 12, 1980

NCI funds biorepository for prostate cancer SPOREs.

November 11, 2005